Narxcare: changing the rules of the game as to who is at risk of overdosing?

Now they are ADDING consideration of  MOUD (medications for opioid use disorder) and this was a new one on me, but a short web search and I found … Buprenorphine, methadone, and naltrexone brought to us by  substance abuse and mental health service administration of our FEDERAL GOVERNMENT https://www.samhsa.gov/medications-substance-use-disorders I guess that Narxcare did not want to leave out those who are in addiction recovery and creating a numerical value assigned to their unintentional overdose risk score.

Another example that DATA is the new GOLD RUSH

 

Dear Prescription Drug Monitoring Program User,

Bamboo Health is excited to announce new NarxCare functionality within the Prescription Drug Monitoring Program beginning on November 15th! This will be available to users accessing Patient Reports via both PMP AWARxE (web portal) and PMP Gateway (integration).

What’s New?

We’ve created a new version of the Overdose Risk Score, which is comprised of two parts:

  1. A new unintentional overdose death risk scoring model
  2. Presentation of key contributing factors to the model’s calculation of the likelihood of unintentional overdose death alongside the model

Why Make These Changes?

Research indicates that contributing factors to unintentional overdose death risk have evolved since launching the initial Overdose Risk Score. In light of these learnings, among other components, the new model:

  • Separates MME (morphine milligram equivalent) from MOUD (medications for opioid use disorder)
  • Focuses on dispensations within the last 365 days, as opposed to a longer period

The new model also benefits from user feedback obtained during pilot implementations.

In addition, a new tile places all scores and the Additional Risk Indicators in one location. This ensures that the controlled substance-specific exposure scores and overdose risk score model are always displayed together. The tile communicates if the score is below average, average or above average with a graphical display. Key Contributing Factors to the unintentional overdose death risk score model are listed on the right hand side of the tile.

We will make additional detail on the new model available to users in the coming weeks. To learn more about NarxCare, please refer to our knowledge center.

We greatly appreciate your support of the PMP! Please contact Bamboo Health with any questions at https://bamboohealth.com/customer-support/.

Thank you!
The Bamboo Health Team

CAUTION / IMPORTANT REMINDER: Pharmacists and physicians use Overdose Risk Scores as indicators to further review details in the patient’s prescription history as they attend to the patients. Overdose Risk Scores are intended to aid, not replace, medical decision-making. Other patient-centric factors, such as mental health conditions (e.g., depression, anxiety, bipolar disorder, dementia), substance use conditions, respiratory conditions, hepatic and renal conditions, and history of overdose, may influence unintentional overdose death but are not incorporated in the PDMP data used to calculate the Overdose Risk Score. None of the information presented should be used as sole justification for providing or refusing to provide medications.

 

One Response

  1. I wonder if NarxCare has ever been studied, as to its accuracy.

    Thanks Steve, for writing these articles and keeping us informed.

Leave a Reply

Discover more from PHARMACIST STEVE

Subscribe now to keep reading and get access to the full archive.

Continue reading